Rodriguez-Castro K, Crafa P, Franceschi M, Franzoni L, Brozzi L, Ferronato A
Acta Biomed. 2022; 93(1):e2022130.
PMID: 35315405
PMC: 8972866.
DOI: 10.23750/abm.v93i1.11987.
Peters Y, van Grinsven E, Siersema P
Aliment Pharmacol Ther. 2021; 54(7):868-879.
PMID: 34383966
PMC: 9292032.
DOI: 10.1111/apt.16558.
van Nistelrooij A, van Marion R, van IJcken W, de Klein A, Wagner A, Biermann K
Fam Cancer. 2017; 17(3):435-440.
PMID: 29134539
PMC: 5999157.
DOI: 10.1007/s10689-017-0054-2.
Contino G, Vaughan T, Whiteman D, Fitzgerald R
Gastroenterology. 2017; 153(3):657-673.e1.
PMID: 28716721
PMC: 6025803.
DOI: 10.1053/j.gastro.2017.07.007.
Sun X, Elston R, Falk G, Grady W, Faulx A, Mittal S
Mol Genet Genomic Med. 2016; 4(4):407-19.
PMID: 27468417
PMC: 4947860.
DOI: 10.1002/mgg3.211.
The Genetics of Barrett's Esophagus: A Familial and Population-Based Perspective.
To H, Clemons N, Duong C, Trainer A, Phillips W
Dig Dis Sci. 2016; 61(7):1826-34.
PMID: 26971090
DOI: 10.1007/s10620-016-4109-2.
Hereditary Factors in Esophageal Adenocarcinoma.
van Nistelrooij A, Dinjens W, Wagner A, Spaander M, van Lanschot J, Wijnhoven B
Gastrointest Tumors. 2015; 1(2):93-8.
PMID: 26675496
PMC: 4645576.
DOI: 10.1159/000362575.
Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence.
Brown C, Ujiki M
World J Gastrointest Endosc. 2015; 7(5):438-45.
PMID: 25992184
PMC: 4436913.
DOI: 10.4253/wjge.v7.i5.438.
Barrett's oesophagus: frequency and prediction of dysplasia and cancer.
Falk G
Best Pract Res Clin Gastroenterol. 2015; 29(1):125-38.
PMID: 25743461
PMC: 4352690.
DOI: 10.1016/j.bpg.2015.01.001.
Influence of Life Style Factors on Barrett's Oesophagus.
Horna Strand A, Franzen T
Gastroenterol Res Pract. 2014; 2014:408470.
PMID: 24971090
PMC: 4058172.
DOI: 10.1155/2014/408470.
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus.
Levine D, Ek W, Zhang R, Liu X, Onstad L, Sather C
Nat Genet. 2013; 45(12):1487-93.
PMID: 24121790
PMC: 3840115.
DOI: 10.1038/ng.2796.
Barrett's oesophagus: epidemiology, cancer risk and implications for management.
de Jonge P, van Blankenstein M, Grady W, Kuipers E
Gut. 2013; 63(1):191-202.
PMID: 24092861
PMC: 6597262.
DOI: 10.1136/gutjnl-2013-305490.
Genomic alterations in advanced esophageal cancer may lead to subtype-specific therapies.
Forde P, Kelly R
Oncologist. 2013; 18(7):823-32.
PMID: 23853247
PMC: 3720637.
DOI: 10.1634/theoncologist.2013-0130.
Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.
Kountourakis P, Ajani J, Davila M, Lee J, Bhutani M, Izzo J
Gastrointest Cancer Res. 2012; 5(2):49-57.
PMID: 22690258
PMC: 3369601.
Prevalence of Barrett esophagus in first-degree relatives of patients with esophageal adenocarcinoma.
Juhasz A, Mittal S, Lee T, Deng C, Chak A, Lynch H
J Clin Gastroenterol. 2011; 45(10):867-71.
PMID: 21617543
PMC: 3189338.
DOI: 10.1097/MCG.0b013e31821f44a8.
Familial Barrett's esophagus: clues to genetic risks for esophageal adenocarcinoma.
Rubenstein J
Dig Dis Sci. 2011; 56(6):1593-5.
PMID: 21461914
DOI: 10.1007/s10620-011-1676-0.
Esophageal adenocarcinoma presenting as pseudo-achalasia in a patient with juvenile polyposis syndrome: an enemy out of the blue.
Chun C, Eisenstat S, Dormady S, Lombard C, Triadafilopoulos G
Dig Dis Sci. 2011; 56(7):1944-8.
PMID: 21267778
DOI: 10.1007/s10620-011-1579-0.
A segregation analysis of Barrett's esophagus and associated adenocarcinomas.
Sun X, Elston R, Barnholtz-Sloan J, Falk G, Grady W, Kinnard M
Cancer Epidemiol Biomarkers Prev. 2010; 19(3):666-74.
PMID: 20200424
PMC: 2838211.
DOI: 10.1158/1055-9965.EPI-09-1136.
Barrett's oesophagus: an ideal model to study cancer genetics.
di Pietro M, Fitzgerald R
Hum Genet. 2009; 126(2):233-46.
PMID: 19365640
DOI: 10.1007/s00439-009-0665-2.
Familial risk for gastric carcinoma: an updated study from Sweden.
Hemminki K, Sundquist J, Ji J
Br J Cancer. 2007; 96(8):1272-7.
PMID: 17406355
PMC: 2360151.
DOI: 10.1038/sj.bjc.6603722.